Show simple item record

dc.contributor.authorFaivre-Finn, Corinne
dc.date.accessioned2020-04-22T07:25:05Z
dc.date.available2020-04-22T07:25:05Z
dc.date.issued2020en
dc.identifier.citationFelip E, Ardizzoni A, Ciuleanu T, Cobo M, Laktionov K, Szilasi M, et al. CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations. European Journal of Cancer. 2020;127:160-72.en
dc.identifier.pmid32171425en
dc.identifier.doi10.1016/s1470-2045(20)30108-xen
dc.identifier.urihttp://hdl.handle.net/10541/622893
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/s1470-2045(20)30108-xen
dc.titleLess is more in radiotherapy target volume planning: lessons from the PET-plan trialen
dc.typeArticleen
dc.contributor.departmentDepartment of Radiotherapy Related Research, University of Manchester, Manchester M20 4BX, UKen
dc.identifier.journalLancet Oncologyen
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record